Zentek (NASDAQ:ZTEK - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.01) EPS for the quarter, Zacks reports. Zentek had a negative return on equity of 53.99% and a negative net margin of 27,217.24%.
Zentek Price Performance
NASDAQ:ZTEK traded up $0.04 during midday trading on Friday, reaching $1.17. 48,428 shares of the stock traded hands, compared to its average volume of 49,134. Zentek has a 12-month low of $0.50 and a 12-month high of $1.34. The business has a 50-day moving average of $1.06 and a two-hundred day moving average of $0.94. The company has a current ratio of 2.06, a quick ratio of 1.63 and a debt-to-equity ratio of 0.01.
Zentek Company Profile
(
Get Free Report)
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.
Recommended Stories
Before you consider Zentek, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.
While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
